When should heparin be given to patients with atrial fibrillation-related embolic brain infarcts?
Caplan
L R
LR
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology; D003657:Decision Making; D004334:Drug Administration Schedule; D004363:Drug Utilization / Q000592:standards; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000150:complications* / Q000209:etiology; D018579:Patient Selection; D012008:Recurrence; D012306:Risk; D016896:Treatment Outcome
D000925:Anticoagulants; D006493:Heparin